Founded in 1855, Children’s Hospital of Philadelphia is the first hospital in the nation dedicated exclusively to pediatrics. It has two inpatient hospital locations, a care network with more than 50 sites and two dedicated behavioral health facilities, one of which includes 30 inpatient psychiatric beds and a 24/7 crisis response center. With 576,800 square feet of dedicated research space and more than 1,130 principal investigators, CHOP is home to dozens of world-renowned research programs focused on translating lab discoveries into new treatments and cures for both common and rare diseases. Some of the most transformational modern-day pediatric breakthroughs began with research at CHOP, including the first cell therapy for cancer, Kymriah, and the first gene therapy for congenital blindness, Luxturna, both of which were approved in the U.S. in 2017. CHOP is also deeply committed to the community, offering over 100 community programs to address key issues including the behavioral health crisis, community violence, and food and housing insecurity. CHOP invested more than $500 million in community benefit in fiscal year 2024 alone. CHOP has been named one of the top pediatric hospitals in the nation by U.S. News & World Report for 19 consecutive years, and is ranked No. 1 in Pennsylvania and is tied for No. 1 in the Mid-Atlantic.
